re-activated t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02577588)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- re-activated t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05341947 | Phase 1 | Jun 30, 2022 | Cedars-Sinai Medical Center |
| NCT02577588 | Phase 1 | May 1, 2016 | German Cancer Research Center, University of Heidelberg |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cedars-Sinai Medical Center | Academic/Hospital | 1 | 1 | 1 | 2022 |
| German Cancer Research Center | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Heidelberg | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1